ALEXANDRIA, Va., Jan. 18 -- Abbvie Stemcentrx, North Chicago, Illinois, has been assigned a patent (No. 10,533,051, initially filed June 5, 2017) developed by seven co-inventors for an "anti SEZ6 antibodies and methods of use." The co-inventors are Laura Saunders, San Francisco, California, Scott J. Dylla, Emerald Hills, California, Orit Foord, Foster City, California, Robert A. Stull, Alameda, California, Michael Torgov, Los Angeles, California, Hui Shao, Foster City, California, and David Liu, . . .